上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
CCR7 Ligand 1 (Synonyms: CCR7-Cmp2105) 纯度: 99.64%
CCR7 Ligand 1 (CCR7-Cmp2105) 是人 CC 趋化因子受体 7 (CCR7) 的变构配体,也是有效的 CCR7 拮抗剂,Kd 值为 3 nM。CCR7 Ligand 1 是一种噻二唑-二氧化物配体,可抑制蛋白与 CCL19 激活反应结合,IC50 为 7.3 μM。
CCR7 Ligand 1 Chemical Structure
CAS No. : 681514-83-0
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
5 mg | ¥5950 | In-stock | |
10 mg | ¥9500 | In-stock | |
50 mg | ¥29500 | In-stock | |
100 mg | 询价 | ||
200 mg | 询价 |
* Please select Quantity before adding items.
CCR7 Ligand 1 相关产品
•相关化合物库:
- Bioactive Compound Library Plus
- GPCR/G Protein Compound Library
- Immunology/Inflammation Compound Library
- Anti-Cancer Compound Library
- Small Molecule Immuno-Oncology Compound Library
- Targeted Diversity Library
生物活性 |
CCR7 Ligand 1 (CCR7-Cmp2105) is an allosteric Ligand and antagonist for human CC chemokine receptor 7 (CCR7) with a Kd of 3 nM. CCR7 Ligand 1, thiadiazole-dioxide ligan, suppresses arrestin binding in response to activation by CCL19 with an IC50 of 7.3 μM[1]. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target[1] |
|
||||||||||||||||
体外研究 (In Vitro) |
CCR7 Ligand 1 (CCR7-Cmp2105) binds to a pocket at the intracellular part of CCR7 between the ends of TM1, TM2, TM3, and TM6 and the loop between TM7 and H8[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
分子量 |
475.56 |
||||||||||||||||
Formula |
C22H29N5O5S |
||||||||||||||||
CAS 号 |
681514-83-0 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
-20°C, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen) |
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 100 mg/mL (210.28 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
||||||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务